Source: Insight Genetics Blog

Insight Genetics Blog A Primer on Matching Donors and Patients for Hematopoietic Stem Cell Transplantation

Hematopoietic stem cell transplantation (HSCT) is considered a curative therapy for a number of patients suffering from certain hematological malignancies and other hematologic or immune disorders. The most favorable patient outcome occurs when the best HSCT donor is found. However, determining which donor will provide the best patient outcome is a complex decision.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Eric B. Dahlhauser's photo - President & CEO of Insight Genetics

President & CEO

Eric B. Dahlhauser

CEO Approval Rating

85/100

Read more